Dr Frederic Mohs carrying out early research to develop the technique. Our thanks to Wisconsin University for the image.
Although Mohs surgery is often regarded as a new approach, the principles were developed in the late 1930s, by a surgeon called Frederic Mohs.
The modern approach retains his concept of treating skin cancer using microscopically controlled surgery. Enhanced by years of research, state of the art equipment, digital microscopy and improved theatre techniques, offering patients proven results.
A surgeon’s skill remains the key but science has brought a greater ability to identify and isolate cancerous cells. Refining a non chemical approach to neutralising them, to the point where this is the treatment of choice in many cases.
Research On Mohs Surgery
For a specialist treatment, Mohs has been well tested in independent medical trials. Results from these trials are consistent.
The cure rate for primary basal cell carcinoma ranges from 97% to 99%. For squamous cell carcinoma, only a little lower at 95% to 96%. Experienced Mohs surgeons have reported similar cure rates.
A substantial study of over 1500 patients focused on assessing safety. They found no major complications, a low postoperative pain level and just 2.6% of patients having minor complications.
Alongside a high degree of safety and being well tolerated by patients, Mohs has continued to improve. Our data and that from leading clinics across the globe suggests a 99% cure rate for common skin cancers.
Research continues on using Mohs surgery for other organs beyond the skin. Most clinicians would accept that for skin cancer treatment, Mohs is a proven technique with exceptional results.
Mohs & Surgical Outcome
A 2004 Maastricht University study concluded that rates of recurrence of facial basal cell carcinoma were lower after Mohs than any other approach, a US assessment came to similar conclusions.
They also commented on the ability of Mohs to reduce the size of skin defects after surgery. Highlighting the value of Mohs for skin cancers on hands, feet, ankles, shins, nipples, or genitals.
The Skin Cancer Foundation described the procedure as elegant and exact. Not words normally applied to surgery but in the right hands, an apt description. You can form your own view by looking at the pros & cons of Mohs, along with wider professional opinions.
They often point out that Mohs should not be seen as expensive, when the cost of additional surgery for incompletely removed cancers is taken into account, as well as the need to repair larger wounds.
That the economics make sense is useful but Skin Care Network specialise in Mohs surgery for the sake of patients and their peace of mind. Knowing that a good solution is available goes beyond cost.